FANJ
ALNY icon

Financial Architects (New Jersey)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Financial Architects (New Jersey)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-160
Closed -$15K – 1189
2019
Q1 		$15K Hold
160
– – ﹤0.01% 976
2018
Q4 		$12K Hold
160
– – ﹤0.01% 947
2018
Q3 		$14K Buy
160
+50
+45% +$5.03K ﹤0.01% 1007
2018
Q2 		$11K Sell
110
-30
-21% -$2.98K ﹤0.01% 955
2018
Q1 		$17K Hold
140
– – ﹤0.01% 918
2017
Q4 		$18K Hold
140
– – ﹤0.01% 981
2017
Q3 		$16K Hold
140
– – ﹤0.01% 1010
2017
Q2 		$11K Buy
140
+60
+75% +$3.83K ﹤0.01% 1103
2017
Q1 		$4K Buy
+80
New +$3.7K ﹤0.01% 1314

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return